Abstract
Hospital-acquired infections (HAIs) pose a worldwide problem. They primarily concern intensive care, hematology-oncology, and surgical units. Coagulase-positive and coagulase-negative Staphylococci, especially their subgroups possessing the ability to develop resistance to methicillin, and Enterococci have a particular role in the etiology of HAIs. The aim of this study was to determine the therapeutic minimal inhibitory concentration (MIC) values for vancomycin and teicoplanin, two of the most commonly administered antibiotics in the treatment of infections caused by Staphylococci resistant to methicillin, and infections caused by Enterococci. The material analyzed included 200 bacterial strains collected from patients treated in the Intensive Care Unit, the Musculoskeletal Infections Unit, and Surgical Clinics of the Military Institute of Medicine in Warsaw, Poland. The study was conducted in accord with the European Committee for Antimicrobial Susceptibility Testing (EUCAST) criteria by means of the Etest® gradient strips. We demonstrate a full susceptibility of Staphylococci MSSA (methicillin susceptible Staphylococcus aureus), Staphylococci MRSA (methicillin resistant Staphylococcus aureus), and Enterococci to both antibiotics. Coagulase-negative Staphylococci had a higher sensitivity to vancomycin. Teicoplanin had a lower MIC than vancomycin against the analyzed strains of Enterococci. As regards the coagulase-negative Staphylococci, vancomycin had a lower MIC than teicoplanin. In conclusion, the study confirmed current recommendations on the use of vancomycin and teicoplanin in the treatment of infections caused by gram-positive bacteria, emphasizing the need for the determination of MIC values.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cetinkaya, Y., Falk, P., & Mayhall, C. (2000). Vancomycin-resistant enterococci. Clinical Microbiology Reviews, 19, 816–822.
Courvalin, P. (2006). Vancomycin resistance in gram-positive cocci. Clinical Infectious Diseases, 42, S25–S34.
Cui, L., Ma, K., Sato, M., Okuma, K., Tenover, F. C., Mamizuka, E. M., Gemmell, C. G., Kim, M. N., Ploy, M. C., El-Solh, N., Ferraz, V., & Hiramatsu, K. (2003). Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. Journal of Clinical Microbiology, 41, 5–14.
Cui, L., Iwamoto, J., Neoh, H., Mruyama, T., Horikawa, Y., & Hiramatsu, K. (2006). Novel mechanisms of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus. Antimicrobial Agents Chemotherapy, 50, 428–438.
Hall, R., Giuliano, C., Haase, K., Hazelwood, K., Frei, C., Forcade, N., Brouse, S., Bell, T., Bedimo, R., & Alvarez, C. (2012). Empiric guide-line-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteraemia: A retrospective cohort study. BMC Infectious Diseases, 12, 104–124.
Hryniewicz, W. (Ed.). (2000). Contemporary views on resistance of bacteria to antibiotics. Infections in intensive care – the place and role of antibiotics (pp. 1–15). Wroclaw: Urban & Partner (in Polish).
Hussain, F., Boyle-Vavra, P., Shete, B., & Daum, R. (2002). Evidence for continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates. Journal of Infectious Diseases, 186, 661–667.
Jain, A., & Agarwal, A. (2009). Biofilm production, a marker of pathogenic potential of colonizing and commensal staphylococci. Journal of Microbiological Methods, 76, 88–92.
Jones, R. N. (2010). Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clinical Infectious Diseases, 51(Suppl 1), S81–S87.
Joukhadar, C. (2001). Impaired target site penetration of b-lactams may account for therapeutic failure in patients with septic shock. Critical Care Medicine, 31, 2102–2109.
Kalil, A. C., Murthy, M. H., Hermsen, E. D., Neto, F. K., Sun, J., & Rupp, M. E. (2010). Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: A systematic review and meta-analysis. Critical Care Medicine, 38, 1802–1808.
Lodise, T., Grawes, A., Evans, A., Graffunder, E., Helmecke, M., Lomaestro, B., & Stellrecht, K. (2008). Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrobial Agents and Chemotherapy, 52, 3315–3320.
Ma, X., Wang, E., Liu, Y., & Luo, E. (2011). Antibiotic susceptibility of coagulase-negative staphylococci (CoNS): Emergence of teicoplanin-non-susceptible CoNS strains with inducible resistance to vancomycin. Journal of Medical Microbiology, 60, 1661–1668.
Mimoz, O., Rolland, D., Adoun, M., Marchand, S., Breilh, D., Brumpt, I., Debaene, B., & Couet, W. (2006). Steady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12 mg/kg per day in patients with ventilator-associated pneumonia. Intensive Care Medicine, 32, 775–779.
Nimmo, G., Pearson, J., Collignon, P., Christiansen, K., Coombs, G., Bell, J., & McLaws, M. (2011). Australian group on antimicrobial resistance. Communicable Diseases Intelligence, 35(3), 237–243.
Piette, A., & Verschragen, G. (2009). Role of coagulase-negative staphylococci in human disease. Veterinary Microbiology, 134, 45–54.
Pitz, A., Yu, E., Hermsen, E., Rupp, M., Fey, P., & Olsen, M. (2011). Vancomycin susceptibility and prevalence of heterogeneous vancomycin-intermediate Staphylococcus aureus in clinical methicillin-resistant S. aureus isolates. Journal of Clinical Microbiology, 49(1), 269–274.
Rybak, M., Leonard, S., Rosii, C., Cheung, C., Sader, H., & Jones, R. (2008). Characterization of vancomycin-hetero resistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007). Journal of Clinical Microbiology, 46, 2950–2954.
Smuszkiewicz, P., Szalek, E., Tomczak, H., Trojanowska, I., & Błaszyk, M. (2007). Pharmacokinetic and pharmacodynamic use of antibiotics in patients treated for sepsis. Anaesthesiology Intensive Therapy, 3, 166–174 (in Polish).
Thierfelder, C., Keller, P., Kocher, C., Gaudenz, R., Hombach, M., Bloemberg, G., & Ruef, C. (2012). Vancomycin-resistant Enterococcus. A multi-strain outbreak of eight weeks duration at a Swiss tertiary care hospital. Swiss Medical Weekly, 5, 1–6.
Wisplinghof, H., Bischoff, T., Tallent, S., Seifert, H., Wenzel, R., & Edmond, M. (2004). Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective national wide surveillance study. Clinical Infectious Diseases, 39, 309–317.
Acknowledgments
We thank Dr. Dariusz Tomaszewski from the Clinic of Anesthesiology and Intensive Care of the Military Institute of Medicine in Warsaw, for stylistic editing of the manuscript.
Conflicts of Interest
The authors declare no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Guzek, A., Korzeniewski, K., Nitsch-Osuch, A., Rybicki, Z., Prokop, E. (2013). In Vitro Susceptibility of Staphylococci and Enterococci to Vancomycin and Teicoplanin. In: Pokorski, M. (eds) Neurobiology of Respiration. Advances in Experimental Medicine and Biology, vol 788. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6627-3_19
Download citation
DOI: https://doi.org/10.1007/978-94-007-6627-3_19
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6626-6
Online ISBN: 978-94-007-6627-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)